Genomic profiling enables therapy individualization when actionable mutations (FLT3, NPM1, IDH1/2, TP53) are present, moving ...

AI is transforming medicine by improving diagnostics, personalized treatments, and operational efficiency. Key opportunities ...

We need investment in precision medicine technologies to start programming cancer against itself, writes Cyriac Roeding.

A long-standing mystery in cancer treatment is how tumor cells so often become resistant to drugs, even ones they have never encountered before.

The idea that modern humans inherited DNA from Neanderthal ancestors is one of the 21st century’s most celebrated discoveries ...

Researchers at NYU Langone Health propose a model that could explain how cancer cells adapt to environmental stress, an ...

Cambridge expertise has been intrinsic to a world first – loading a complete genome onto a quantum computer. The milestone ...

This week's cover of the international journal 'Nature' features a circular geometric painting inspired by the 'Orphism' of ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the acceptance of 31 abstracts-including one oral presentation-for the ...

Researchers at NYU Langone Health propose a model that could explain how cancer cells adapt to environmental stress, an approach that may lead to new ...

It couldn’t come at a better time, considering that cancer rates are rising among younger women.

Tempus AI TEM shares are up on Tuesday as the company announced the acceptance of 31 abstracts for presentation at the ...